SARS-Coronavirus ancestor's foot-prints in Thai bat colonies and the refuge theory: A phylogeography perspective  by Le Gouil, M. et al.
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softwares to predict the protein conformation and hydropho-
icity. 3D structures with the highest C-score were considered.
e looked at the different HA conformations in the presence or
bsence of non-glycosylated Asn415/416 and Asn472-473 residues
nd correlated this with inﬂuenza transmission patterns and
athogenicity.
Results: Through 1918-2012 we found that non-glycosylated
sn residues are conserved at the amino- and carboxyl-terminal
egion of the 53-residue long alpha-helix uniquely found in HA2.
e found that the amino-terminus will either have a single Asn
esidue or an Asn-Asn doublet whereas the carboxyl-terminus
ill always have an Asn-Asn doublet. Interestingly, we found that
henever Asn415-Xxx416 (where X is any amino acid residue) is
he same in two species, HA1 conformation is the same and inter-
pecies transmission of the virus occurs. Moreover, whenever a
hift from a single Asn415 residue to an Asn415-Asn416 doublet
r vice-versa occurs in the amino-terminus, it results to signiﬁ-
ant structural changes in HA1 which surprisingly coincides with
he 1918 Spanish ﬂu, 1977 Russian ﬂu and 2009 Swine ﬂu. Struc-
ural analyses using the 2009 HA show that mutations at either
sn415 or His416 has no change in HA1 conformation, however,
hen both were changed, HA1 conforms to the 1977 HA. Similarly,
e observed that mutations at Asn472, Asn473 or both results into
he 1977 HA.
Conclusion: Non-glycosylated Asn415 and Asn472-Asn473
oublet can inﬂuence HA1 conformation. In addition, Asn415-
xx416 pairs can determine interspecies transmission and
athogenicity of the H1N1 inﬂuenza virus.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.123
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ucleic acid-based drugs against the highly pathogenic H5N1
vian inﬂuenza virus infection
. Wong1,∗, L.Q. Sun2, M. Wang2
Defence R&D Canada - Sufﬁeld, Medicine Hat, AB, Canada
China Agriculture University, Beijing, China
Background: Highly pathogenic H5N1 avian inﬂuenza virus
HPAIV) continues to cause serious global concerns because it
hreathens the poultry industry and causes loss of human lives. The
bility of HPAIV tomutate and develop resistance to antiviral drugs
nd vaccines necessitates the development of novel drugs and
accines, including those which are nucleic acid-based. Liposome-
ncapsulated Poly ICLC (a ds RNA and a toll-like receptor-3 [TLR-3]
gonist) and antisense oligonucleotides are examples of nucleic
cid-based drugs which can be safe and efﬁcacious against HPAIV.
Methods: Using a lethal Balb/c mouse model, liposome-
ncapsulated Poly ICLC and antisense oligonucleotides (directed
gainst the hemagglutinin protein) were evaluated for their pro-
hylactic or therapeutic efﬁcacy against a wild strain (inﬂuenza
/H5N1/chicken/Henan/2005) of HPAIV. Liposome-encapsulated
oly ICLC were administered intranasally at day -3 and day -1 prior
o HPAIV challenge, and antisense oligonucleotides were adminis-
ered intranasally at 4 and 8 hours post virus challenge. Antiviral
fﬁcacies were determined by comparing the survival rates ofnfectious Diseases 16S (2012) e2–e157
drug-treated mice at day 14 post infection compared to control
saline group.
Results: Depending to various challenge doses of HPAIV,
liposome-encapsulated Poly ICLC administered intranasally pro-
vided 67-100% protection when given at up to 24 and 48 hrs prior
to virus challenge. RT-PCR analysis of lungs tissues of LE Poly ICLC
treated mice indicated up-regulation of TLR-3 and antiviral inter-
ferons (-, -  and -) mRNAs production. Treatment of mice
with antisense oligonucleotides administered to mice at 4 and 8
hours post infection were completely protected against a 10 lethal
dose virus challenge with inﬂuenza A/H5N1/chicken/Henan/2005,
or with inﬂuenza A/PR/8/34 (H1N1). However, therapeutic efﬁcacy
of antisense oligonucleotide decreased when treatment with anti-
sense was delayed beyond 8 hours post infection.
Conclusion: Liposome-encapsulated Poly ICLC provided high
level of protection inmice against lethal dosesofHPAIV, andagainst
a seasonal strain of inﬂuenza A/PR/8/34 virus (H1N1). Activation of
TLR-3 signaling pathway can provide broad-spectrum protection
against various strains of inﬂuenza virus, regardless of muta-
tions. Post-exposure treatment of HPAIV can be achieved through
silencing of inﬂuenza virus gene expression using virus-speciﬁc
antisense oligonucleotides. These ﬁndings support the potential
role of nucleic acid-based drugs for prevention and treatment of
HPAIV.
http://dx.doi.org/10.1016/j.ijid.2012.05.124
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SARS-Coronavirusancestor’s foot-prints inThaibat coloniesand
the refuge theory: A phylogeography perspective
M. Le Gouil1,∗, S. Puechmaille2, J.-P. Gonzalez3, E. Teeling2, P.
Kittayapong4, J.-C. Manuguerra1
1 Institut Pasteur, Paris, France
2 University College Dublin, Dublin, Ireland
3 Centre International de Recherche Médicale de Franceville, Libreville,
Gabon
4 Mahidol University, Faculty of Science, Nakhonpathom, Thailand
Background: Elucidating relations between viruses and their
hosts remains one of the great challenges of the ecology of infec-
tious diseases and may help in identifying drivers of emergence of
new pathogens. Following the emergence of SARS, several studies
have pointed out the great diversity of Alphacoronavirus and Beta-
coronavirus in bats as well as the existence of SARS-related-CoV
infection in apparently healthy bats. To date, the greatest Coron-
avirinae diversity has been observed in Microchiroptera and the
closest wild virus to SARS-CoV has been detected in this group as
well, and more precisely in the Rhinolophoidea super-family. The
Rhinolophidae were ﬁrstly recognized to host SARS-CoV related
Coronavirinae and therefore were the most represented bat fam-
ily in the sampling record. Consequently, their sister group, the
Hipposideridae, were less considered in studies focusing on Coron-
avirinae ecology. Given the phylogenetic proximity of these twobat
families, their broad and partially sympatric repartition and their
diversiﬁed behavior, we hypothesized that they might both harbor
betacoronaviruses related to SARS-CoV inAsia and that the study of
their phylogeny may help to understand the genesis of SARS-CoV.
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Methods: This work integrates hosts ecology, biogeography,
omparative hosts- pathogens phylogeny to propose one hypoth-
sis about the making of the SARS-CoV ancestor. The Coronavirinae
olymerase sequence has been targeted by Rt-PCR in non-
nvasive samples from bats collected in isolated and forested area
n Thailand. A Coronavirinae phylogeny based on all available
equences have been inferred by several methods.
Results: Two new coronaviruses were detected in two Hip-
osideridae bat species in Thailand: one Betacoronavirus-b that
xhibited long-lasting infection in an isolated bat colony and one
lphacoronavirus in another colony. Interestingly, viruses detected
n Africa or in Europe are related to those that currently circulate
n South-East Asia, reminding the underlying inﬂuence of the host
hylogeny on the Coronavirinae phylogeny.
Conclusion: These ﬁndings illuminate the origin and the natu-
al history of the Rhinolophus-hosted SARS-CoV lineage by pushing
orward the hypothesis of a Betacoronavirus spill-over from Hip-
osideridae to Rhinolophidae and then from Rhinolophidae to
ivets and Human. The common ancestor of Hipposideridae and
hinolophidae families is a key taxa in the understanding of the
ctual repartition of Betacoronaviruses.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.125
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irst multicentre evaluation of serological and molecular diag-
ostic assays for Crimean-Congo hemorrhagic fever
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Background: Crimean Congo Haemorrhagic Fever (CCHF) is a
iral tick-borne disease that occurs widely in Africa, Asia, and
astern Europe. The disease can develop severe illness in humans
ith case-fatality rates as high as 50%. The emergence of CCHF
oses a serious public health threat due to its high contagious-
ess, high lethality, potential for nosocomial spread and difﬁculties
n treatment and control. A strong laboratory capacity, in particu-
ar standardized approaches for diagnostic methods, is essential to
ncrease preparedness in countries at risk. We describe the ﬁrstnfectious Diseases 16S (2012) e2–e157 e51
evaluation study of available molecular and serological methods
targeting CCHF.
Methods: Two serological tests, an enzyme-linked immunosor-
bent assay (ELISA)* and an indirect immunoﬂuorescence assay
(IFA)** and two molecular methods, a real time quantitative
reverse-transcription PCR (qRT-PCR)*** and a low-cost, low-
density array (LCD)**** were selected based on a systematic review
of the literature. Performances of the selected methods were
compared with in house reference methods employed by the 5
participating expert laboratories, using panels of archived patient
samples from geographically diverse settings.
*Vektor-Best
**Euroimmun
***Altona-Diagnostics
****Wolfel et al., 2007
Results: Sample panels included 66 sera and 54 serum RNA
extracts from patients with conﬁrmed CCHF diagnosis, and 73 sera
and 21 serum RNA extracts from febrile patients with symptoms
compatible with CCHF or from healthy individuals. When com-
pared to the reference tests, the observed sensitivity of the IgM-
and IgG-ELISA was 87.8% and 80.4%, respectively. For the IgM- and
IgG-IFA, the sensitivity was 93.9%, and 86.1%, respectively. Molec-
ular assays showed more modest sensitivities: 79.6% and 83.3% for
the qRT-PCR and LCD array, respectively. Speciﬁcity was excellent
for all assays.
Conclusion: This study demonstrated that reliable, well-
characterized serological and molecular assays and protocols are
available for CCHF diagnosis. Our results are consistent with the
ﬁnding that the application ofmolecular assays in different settings
is hampered by the high diversity of the CCHF genomes. The on-
site use of such standardized CCHF diagnostic assays by outbreak
assistance laboratories would be more time- and cost-effective,
and greatly diminish the risks posed by the handling, packaging
and shipping of highly infectious biological material to reference
laboratories abroad.
http://dx.doi.org/10.1016/j.ijid.2012.05.126
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Safety and immunogenicity of INV21, an inactivated vaccine
candidate for the prevention of hand, foot and mouth disease
caused by enterovirus 71
P. Tambyah1,∗, J. Oon1, R. Asli 1, W. Kristanto1, G. Gordon2, J.
Santangelo3, D. Stinchcomb2, C. Thomson3
1 National University Hospital, Singapore, Singapore
2 Inviragen Inc., Ft Collins, CO, USA
3 Inviragen Pte Ltd, Singapore, Singapore
Background:Hand foot andmouth disease (HFMD) is caused by
enteroviral pathogens such as enterovirus 71 (EV71). Characteris-
tically a self-limiting disease indicated by fever, mouth ulcers, and
rash, HFMD caused by EV71 can lead to viralmeningo-encephalitis,
myocarditis or poliomyelitis-like paralysis, and may be fatal. EV71
and HFMD are endemic in Asia, causing signiﬁcant morbidity, mor-
tality and economic impact in recent years. INV21 is a puriﬁed,
